Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.40 |
| ▸ | MGLL | Q99685 | 4/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.39 |
| ▸ | JAK2 | O60674 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | GPX4 | P36969 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.38 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.38 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.38 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15020737 | 0.84 | PLA2G2A (0.45) | NPC1RAB9APAX8JAK2ALDH1A1 | |
| SCHEMBL4024848 | 0.73 | NPC1 (0.68) | NPC1RAB9APAX8JAK2ALDH1A1 | |
| SCHEMBL7096422 | 0.73 | NPC1 (0.68) | NPC1RAB9APAX8JAK2ALDH1A1 | |
| SCHEMBL1082836 | 0.73 | NPC1 (0.68) | NPC1RAB9APAX8JAK2ALDH1A1 | |
| SCHEMBL11344796 | 0.73 | NPC1 (0.68) | NPC1RAB9APAX8JAK2ALDH1A1 | |
| SCHEMBL6424475 | 0.73 | NPC1 (0.68) | NPC1RAB9APAX8JAK2ALDH1A1 | |
| SCHEMBL11344801 | 0.73 | NPC1 (0.68) | NPC1RAB9APAX8JAK2ALDH1A1 | |
| SCHEMBL4680424 | 0.72 | NPC1 (0.49) | NPC1RAB9APAX8JAK2ALDH1A1 | |
| SCHEMBL7268930 | 0.72 | NPC1 (0.50) | ESR1NPC1RAB9APAX8JAK2 | |
| SCHEMBL8756523 | 0.72 | NPC1 (0.50) | ESR1NPC1RAB9APAX8JAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2316819-B1 | Self-assembled nanostructures | XEROX CORP (US) | 2017-11-08 | — | — | EP | disclosed |
| US-9623345-B2 | Phase selective gelation with alkylated aromatic acid compounds | XEROX CORPORATION (US) | 2017-04-18 | — | — | US | disclosed |
| US-9067878-B2 | Organogel compositions comprising alkylated aromatic acids | XEROX CORPORATION (US) | 2015-06-30 | — | — | US | disclosed |
| US-8703988-B2 | Self-assembled nanostructures | XEROX CORPORATION (US) | 2014-04-22 | — | — | US | disclosed |
| US-20130158135-A1 | Organogel Compositions Comprising Alkylated Aromatic Acids | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2013-06-20 | — | — | US | disclosed |
| US-20130153508-A1 | Phase Selective Gelation With Alkylated Aromatic Acid Compounds | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2013-06-20 | — | — | US | disclosed |
| US-20110311813-A1 | SELF-ASSEMBLED NANOSTRUCTURES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2011-12-22 | — | — | US | disclosed |
| EP-2316819-A2 | Self-assembled nanostructures | Xerox Corporation (US) | 2011-05-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130158135-A1 | Organogel Compositions Comprising Alkylated Aromatic Acids | F12, AHR, RXRG | ESR1 763/4885MGLL 1024/4885NPC1 3728/4885 |
| US-20110311813-A1 | SELF-ASSEMBLED NANOSTRUCTURES | ARG1, H1-3, H1-4 | ESR1 771/4885MGLL 3578/4885NPC1 1251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.